Rheinland Bio-Industrial Hemp production capacity ranks first in the United States, the second curve opens the stock price and closes two daily limits

Original title: Rheinland Bio-Industrial Hemp Capacity Ranks First in the United States

Changjiang Commercial Daily News Pan Ruidong, a trainee reporter of Changjiang Commercial Daily

The mass production of overseas projects of industrial hemp concept stock Rhein Bio (002166.

On the evening of June 28, Rhein Biotech announced that its industrial hemp project in the United States has launched large-scale feeding and officially entered the stage of mass production

Rheinland focuses on the research and development and production of functional plant ingredients, of which 60% of its revenue comes from the natural sweetener business

In this context, RheinBio is betting on the industrial hemp track to expand the second curve

The "troubles" of sweeteners

According to public information, Rhine Biotech has been deeply involved in the plant extraction industry for more than 20 years, and has relatively mature experience in the production, sales and process technology of natural sweeteners stevia extract and Luo Han Guo extract.

Stevia extract and Luo Han Guo extract are the star varieties of the contemporary sugar industry.

According to the financial report, Rhine Biosciences will achieve revenue of 1.

Under the background of the "big single product" strategy, Rheinland Bio's natural sweeteners have made great progress in revenue.

According to industry insiders, the relatively single product structure makes Rhein Bio's business performance highly dependent on the sales of natural sweeteners

In fact, the "troubles" of Rhine Bio's originating from large single-product sweeteners do not stop there

In this regard, Rheinland explained that the main reason is that the company has signed a "commercial contract" with a strategic customer Firmenich with a cumulative target revenue of 400 million US dollars.

RheinBio is also aware of the risk of customer concentration, and will start to expand the domestic natural sweetener market in 2021.

Betting on the hemp track

In order to get rid of dependence on large single products and alleviate the risk of excessive customer concentration, RheinBio is developing a second growth track

Recently, Rhine Biotech announced that its U.

According to the data, the main functional components of industrial hemp extraction products are CBD (cannabidiol) and its corresponding derivatives, which have shown significant effects in anti-epileptic, anti-anxiety, anti-inflammatory, anti-emetic, sleep-improving, analgesic and other aspects

According to NewFrontierData, the global industrial hemp market is expected to grow at a compound annual growth rate of 34% from $4.

Rheinland ranks first in the United States in the industrial capacity of industrial hemp CBD extraction in the United States, and is one of the few industrial hemp extraction manufacturers in the United States that have achieved large-scale and industrialized production
.

Retrospective announcement, on March 21, 2022, Rhein Biotech disclosed that its grandson company Hemprise signed an "Entrusted Processing Intention Agreement" with a U.
S.
industrial hemp product provider.
The company is a mainstream company in the global industrial hemp market, focusing on for the supply of cannabis derivatives and cannabidiol products to the healthcare sector
.

Since then, Rhine Biotech has achieved 4 daily limits in 6 trading days, during which the stock price has risen by 63%
.

It is worth mentioning that the above-mentioned industrial hemp project was changed from the original investment project of Rheinland Biotech “Stevioside Standardized Planting Base Construction Project”
.
According to its announcement on September 16, 2019, the project involved a total of about 335 million yuan of raised funds, accounting for 71.
26% of the net raised funds of 470 million yuan and 101.
64% of the original planned investment of the changed project of 330 million yuan
.

According to Rheinland Biotech, the total investment in the U.
S.
industrial hemp project is expected to reach about 80 million US dollars, and automatic extraction and production will be realized
.

Recently, affected by the news of the mass production of industrial hemp projects in the United States, Rheinland’s stock price has risen by the limit for two consecutive trading days, with a cumulative increase of 20%.
On June 29, Rheinland shares rose 0.
33% to close at 12.
22 yuan per share
.

Editor in charge: ZB

Editor: